Stephens & Co. Maintains Equal-Weight on Myriad Genetics, Raises Price Target to $6
Myriad Genetics, Inc. (MYGN) Presents at 2026 UBS Global Healthcare Conference Transcript
Myriad Genetics’s Q3 2026 earnings call: our top 5 analyst questions
Myriad Genetics, Inc. 2026 Q3 - Results - Earnings Call Presentation
Myriad Genetics (MYGN) Q3 2026 Earnings Call Transcript
TD Cowen Maintains Hold on Myriad Genetics, Raises Price Target to $6.75
Leerink Partners Maintains Market Perform on Myriad Genetics, Raises Price Target to $8
Myriad Genetics, Inc. (MYGN) Q3 2026 Earnings Call Transcript
Myriad Genetics Detects Unauthorized Access In It Network On Nov. 2; Temporarily Suspended Testing Operations, Order Management Systems Due To Incident; Probing Potential Access To Patient Records
Myriad Genetics Inc (MYGN) Q3 2026 Earnings Call Highlights: Revenue Guidance Raised as ...
Myriad Genetics (NASDAQ:MYGN) Q3 Beats Estimates, Raises Guidance, and Strikes Prenatal Sale to Labcorp
Myriad: Q3 Earnings Snapshot
Myriad Genetics (NASDAQ:MYGN) reports upbeat Q3 2026, stock jumps 10.7%
Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Support Strategic Growth Initiatives
Myriad Genetics Q3 2026 Earnings Call Transcript
Myriad Genetics Raises FY2026 Sales Guidance from $770.000M-$790.000M to $780.000M-$790.000M vs $777.921M Est
Myriad Genetics Q3 Adj. EPS $(0.11) Beats $(0.20) Estimate, Sales $202.700M Beat $191.329M Estimate
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Myriad Genetics (MYGN) Stock Sees Fair Value Lift After Split Analyst Revisions
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.